YC8-02

N/A

Report date: 2024/09/20 14:48:05
NME

Base Information

Drug NameYC8-02
Drug Alias NameYC8-02YC-8-02
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD-dependent protein deacetylase sirtuin-3, mitochondrial inhibitors
TargetsNAD-dependent protein deacetylase sirtuin-3, mitochondrial
Therapy Area/IndicationsLymphoma, Large B-Cell, Diffuse
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCornell University
China Registration ClassN/A

Develop Information

Active CompaniesCornell University
Inactive CompaniesN/A
Active IndicationsLymphoma, Large B-Cell, Diffuse
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A